Cargando...
Cardiovascular risk of sitagliptin in treating patients with type 2 diabetes mellitus
Patients with type 2 diabetes mellitus (T2DM) have a very high risk of cardiovascular related events, and reducing complications is an important evaluation criterion of efficacy and safety of hypoglycemic drugs. Previous studies have shown that the dipeptidyl peptidase-4 (DPP-4) inhibitors (DPP4i),...
Guardado en:
| Publicado en: | Biosci Rep |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Portland Press Ltd.
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6629947/ https://ncbi.nlm.nih.gov/pubmed/31262972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20190980 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|